(HealthDay News) — Among survivors of drug overdose, fewer than half visited the emergency department, according to a study published online in JAMA Network Open.

(HealthDay News) — Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases compared with sulfonylureas among adults with type 2 diabetes ...

Cardiovascular, kidney, and metabolic (CKM) syndrome affects nearly 90% of adults in the US, but most people don't know it. (HealthDay News) — Most U.S. adults have not heard of ...

A substudy of the phase 1/2 KEYMAKER-U03 trial tested novel pembrolizumab-based triplet regimens for first-line treatment of advanced clear cell renal cell carcinoma (ccRCC).

Cancer deaths have increased by more than 70% globally over the last 3 decades and are estimated to continue to climb, researchers report.

Enzalutamide plus leuprolide reduces the risk of death by more than 40% in biochemically recurrent prostate cancer compared to leuprolide alone.

In MIBC patients, ctDNA-guided, adjuvant atezolizumab treatment is associated with significant survival improvements over placebo.

Higher prevalence was seen for antiviral-treated patients compared with untreated counterparts. (HealthDay News) — Patients with chronic hepatitis B (CHB) have an increased prevalence of chronic ...

(HealthDay News) — Overdose deaths in older adults from fentanyl mixed with stimulants, such as cocaine and methamphetamine, have surged in the past eight years, according to a study presented at the ...

Association between continued smoking and all-cause mortality also seen in patients with advanced-stage cancer.